Discuss This Disease

4 free views remaining today

endocrine-cerebro-osteodysplasia syndrome

ICD-10 Codes

Related ICD-10:

Description

Endocrine-cerebro-osteodysplasia (ECO) syndrome is a rare and severe genetic disorder that affects multiple systems in the body, including the endocrine, cerebral, and skeletal systems.

Characteristics of ECO Syndrome

  • Multiple congenital defects: ECO syndrome is characterized by various anomalies of the endocrine, cerebral, and skeletal systems [1][2][3].
  • Neonatal mortality: The syndrome leads to neonatal mortality due to the severity of its symptoms [4][5].
  • Endocrine system involvement: The endocrine system is affected, leading to abnormalities in hormone production and regulation [6].
  • Cerebral system involvement: The cerebral system is also affected, resulting in neurological problems and developmental delays [7].
  • Skeletal system involvement: The skeletal system is impacted, causing birth defects and abnormalities in bone development [8].

Causes of ECO Syndrome

The exact cause of ECO syndrome is not well understood, but it is believed to be a genetic disorder caused by mutations in specific genes. A novel mutation in the ICK gene has been identified as a cause of ciliary disruption and lethal endocrine-cerebro-osteodysplasia syndrome [8].

References

[1] Context result 1: Endocrine-cerebro-osteodysplasia (ECO) syndrome is characterized by various anomalies of the endocrine, cerebral, and skeletal systems resulting in neonatal ...

[2] Context result 6: Endocrine-cerebro-osteodysplasia (ECO) syndrome is characterized by various anomalies of the endocrine, cerebral, and skeletal systems resulting in neonatal ...

[3] Context result 7: Endocrine-cerebro-osteodysplasia (ECO) syndrome is characterized by various anomalies of the endocrine, cerebral, and skeletal systems resulting in neonatal ...

[4] Context result 5: A syndrome that is characterized by multiple congenital defects in endocrine, cerebral, and skeletal systems leading to neonatal mortality; it has material ...

[5] Context result 9: Disease Ontology Definition:A syndrome that is characterized by multiple congenital defects in endocrine, cerebral, and skeletal systems leading to neonatal ...

[6] Context result 1: Endocrine-cerebro-osteodysplasia (ECO) syndrome is characterized by various anomalies of the endocrine, cerebral, and skeletal systems resulting in neonatal ...

[7] Context result 3: Endocrine-cerebro-osteodysplasia (ECO) syndrome is characterized by various anomalies of the endocrine, cerebral, and skeletal systems resulting in neonatal ...

[8] Context result 8: A novel ICK mutation causes ciliary disruption and lethal endocrine-cerebro-osteodysplasia syndrome. Machteld M. Oud,; Carine Bonnard, ...

Additional Characteristics

  • Multiple congenital defects
  • Neonatal mortality
  • Endocrine system involvement
  • Cerebral system involvement
  • Skeletal system involvement
  • Genetic disorder caused by mutations in specific genes
  • Novel mutation in the ICK gene causes ciliary disruption and lethal endocrine-cerebro-osteodysplasia syndrome

Signs and Symptoms

Endocrine-cerebro-osteodysplasia (ECO) syndrome is a rare genetic disorder characterized by congenital defects in the endocrine, cerebral, and skeletal systems. The affected newborns exhibit various signs and symptoms, including:

  • Abnormal facial features, such as widely spaced eyes [3]
  • Hypoplasia of the thorax (underdeveloped chest cavity)
  • Scoliosis (curvature of the spine)
  • Shortened digits (fingers or toes)
  • Bowed long bones
  • Respiratory distress and failure to thrive in neonates

These symptoms can vary in severity and may be accompanied by other complications, such as heart defects, cleft palate, and developmental delays [5]. The syndrome is often associated with a high risk of neonatal mortality.

References: [1] - Characterized by various anomalies of the endocrine, cerebral, and skeletal systems resulting in neonatal ... [2] - Description. Endocrine-cerebro-osteodysplasia (ECO) syndrome is characterized by various anomalies of the endocrine, cerebral, and skeletal systems ... [3] - Manifestations include abnormal facial features (such as widely spaced eyes), hypoplasia of the thorax, scoliosis, shortened digits, bowed long ... [5] - Endocrine-cerebro-osteodysplasia (ECO) syndrome is a genetic disorder associated with congenital defects of the endocrine, cerebral, and skeletal systems in ...

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Endocrine-Cerebro-Osteodysplasia Syndrome

Endocrine-cerebro-osteodysplasia (ECO) syndrome is a rare genetic disorder that affects multiple systems in the body. Diagnostic tests are essential to confirm the presence of this condition.

  • Genetic Testing: Genetic testing can identify mutations in the ICK gene, which is associated with ECO syndrome [3]. This test can be performed on blood samples or other tissues.
  • Clinical Genetic Tests: Clinical genetic tests, such as those offered by Intergen, can also diagnose ECO syndrome by analyzing genes related to conditions affecting the skeletal system [3].
  • Antenatal and Post-natal Diagnosis: Diagnostic tests for antenatal (prenatal) and post-natal diagnosis of ECO syndrome are available through Eurofins Humangenetik [4].

Other Relevant Information

  • The Invitae Skeletal Disorders Panel analyzes genes associated with conditions affecting the skeletal system, which may be relevant to diagnosing ECO syndrome [5].
  • Research studies have shown that activation of sonic hedgehog signaling can restore congenital defects in mouse models of ECO syndrome [9][10].

References

[3] Clinical Genetic Test offered by Intergen for conditions (1): Endocrine-cerebro-osteodysplasia syndrome; Testing genes (1): CILK1 (6p12.1); ... [4] Nov 14, 2024 — ... Diagnosis of endocrine-cerebro-osteodysplasia syndrome (ICK gene). Eurofins Humangenetik. Purpose(s): Antenatal diagnosis - Post-natal diagnosis. [5] Test description​​ The Invitae Skeletal Disorders Panel analyzes genes that are associated with conditions affecting the skeletal system. These are genetically ... [9] by JO Shin · 2019 · Cited by 19 — Activation of sonic hedgehog signaling by a Smoothened agonist restores congenital defects in mouse models of endocrine-cerebro-osteodysplasia syndrome. [10] by JO Shin · 2019 · Cited by 19 — Activation of sonic hedgehog signaling by a Smoothened agonist restores congenital defects in mouse models of endocrine-cerebro-osteodysplasia ...

Additional Diagnostic Tests

  • Genetic Testing
  • Clinical Genetic Tests
  • Antenatal and Post-natal Diagnosis

Treatment

Unfortunately, there is no known effective treatment for endocrine-cerebro-osteodysplasia (ECO) syndrome. According to search result [3], it is stated that "No treatment is known" for this condition.

However, research has been conducted on the potential therapeutic effects of activating sonic hedgehog signaling in mouse models of ECO syndrome. As per search results [2] and [5], activation of sonic hedgehog signaling by a Smoothened agonist was found to restore congenital defects in mouse models of endocrine-cerebro-osteodysplasia syndrome.

It is essential to consult with a healthcare professional for medical advice and treatment, as stated in search result [3]. They can provide personalized guidance based on the individual's specific condition and needs.

In summary:

  • No known effective treatment exists for ECO syndrome.
  • Research suggests that activating sonic hedgehog signaling may have therapeutic effects in mouse models of ECO syndrome.
  • Consultation with a healthcare professional is necessary for medical advice and treatment.

Recommended Medications

  • No known effective treatment
  • Consultation with a healthcare professional
  • agonist

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Understanding Differential Diagnosis

A differential diagnosis is a process used by medical professionals to determine the possible causes of a patient's symptoms or condition. In the case of endocrine-cerebro-osteodysplasia (ECO) syndrome, a differential diagnosis would involve considering various conditions that may present with similar symptoms.

Conditions Considered in Differential Diagnosis

According to recent studies [1][2], a differential diagnosis for ECO syndrome may include:

  • SRTD (Short-Rib Polydactyly Syndrome): A rare genetic disorder characterized by short ribs, polydactyly, and other skeletal abnormalities.
  • CILK1-related disorders: A group of conditions caused by mutations in the CILK1 gene, which can lead to ECO syndrome-like symptoms.

Key Factors in Differential Diagnosis

When considering a differential diagnosis for ECO syndrome, medical professionals may take into account factors such as:

  • Genetic testing: Results from genetic tests can help identify specific mutations or conditions that may be contributing to the patient's symptoms.
  • Clinical presentation: The patient's overall clinical presentation, including their medical history, physical examination findings, and laboratory results, can provide clues about the underlying condition.

References

[1] Oud MM. A novel ICK mutation causes ciliary disruption and lethal endocrine-cerebro-osteodysplasia syndrome. Cilia 2016;5(1):10.1186/s13630-016-0029-1.

[2] Unger S. Nosology of genetic disorders: a guide for differential diagnosis. 2023.

Note: The above response is based on the information provided in the search results, specifically references [1][2].

Additional Differential Diagnoses

  • SRTD (Short-Rib Polydactyly Syndrome)
  • CILK1-related disorders

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1626
owl#annotatedSource
t341129
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
ORDO:199332
oboInOwl#id
DOID:0060641
core#notation
DOID:0060641
IAO_0000115
A syndrome that is characterized by multiple congenital defects in endocrine, cerebral, and skeletal systems leading to neonatal mortality; it has_material_basis_in mutation in the gene encoding intestinal cell kinase.
oboInOwl#hasExactSynonym
ECO syndrome
rdf-schema#label
endocrine-cerebro-osteodysplasia syndrome
rdf-schema#subClassOf
t340840
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
relatedICD
http://example.org/icd10/Q87.8
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.